The role of rapid estrogen signaling in alcohol drinking behavior
- Institution
- WEILL MEDICAL COLL OF CORNELL UNIV, NY
- Principal investigator
- Kristen Elizabeth Pleil
- Funding
- $655K
- Duration
- 2019–2029
Moonbase score
Still being scored
Abstract
Project Summary/Abstract Binge alcohol drinking is a major risk factor for many diseases, including alcohol use disorder (AUD) and other neuropsychiatric diseases, and women are at greater risk for developing AUD than men with the same history of alcohol use. The sex hormone estrogen, which fluctuates across the menstrual/estrous cycle in females, has been implicated in playing a regulatory role in alcohol drinking behavior across mammalian species, but the specific mechanisms underlying this function are not well understood. We recently found that ovarian estrogen acts via rapid, nongenomic signaling at membrane-associated estrogen receptors in the limbic system to drive binge alcohol drinking behavior in gonadally intact female mice. We hypothesize that estrogen regulates presynaptic neurotransmitter release and postsynaptic excitability in a coordinated fashion to regulate the activation and signaling of critical neuropeptidergic circuits that promote alcohol use. In the proposed work, we examine the circuit and receptor signaling context for rapid E2 modulation of neuronal function that drives binge alcohol drinking in intact female mice. These studies will improve our understanding of this behavior in females, potentially providing new avenues for pharmacotherapeutic approaches to curbing excessive alcohol consumption.
LOADING MOONBASE SCORE
Questions for WEILL MEDICAL COLL OF CORNELL UNIV
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Weill Medical Coll of Cornell UnivNot yet scored
Predoctoral Training in Pharmacological Sciences
Kristen Elizabeth Pleil · $426K · 2021–2026
- NIH · Weill Medical Coll of Cornell Univ63
Mechanistic Assessment of N-Acetylcysteine as an Antioxidant Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Through Dose Response and Treatment Target Engagement
Dikoma C Shungu · $525K · 2020–2026
- NIH · Weill Medical Coll of Cornell Univ53
Molecular Phenotyping and Image-Guidance for Surgical Treatment of High-Risk Prostate Cancer Using Ultrasmall Silica Nanoparticles
Michelle S Bradbury · $318K · 2023–2026